Alteration of the gut microbiome in mycophenolate-induced enteropathy: impacts on the profile of short-chain fatty acids in a mouse model

BACKGROUND: Mycophenolic acid (MPA) is the most widely used immunosuppressive drug in transplantation and for autoimmune diseases. Unfortunately, more than 30% of patients experience a typical gastrointestinal adverse effect also referred to as mycophenolate-induced enteropathy. Due to its antibacte...

Descripción completa

Detalles Bibliográficos
Autores principales: Jardou, Manon, Provost, Quentin, Brossier, Clarisse, Pinault, Émilie, Sauvage, François-Ludovic, Lawson, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555345/
https://www.ncbi.nlm.nih.gov/pubmed/34711288
http://dx.doi.org/10.1186/s40360-021-00536-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555345/
https://www.ncbi.nlm.nih.gov/pubmed/34711288
http://dx.doi.org/10.1186/s40360-021-00536-4

Ejemplares similares